G01N 2333/9723
Urokinase
G01N2333/9723 (Urokinase) appears on 41 US grants and 33 published applications in this corpus.
Search patents in G01N- Granted patents
- 41
- Published applications
- 33
- Assignees
- 42
- Inventors
- 135
- Latest grant
- 22 Sep 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 4 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 5 |
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 3 |
| 2009 | 1 | 4 |
| 2010 | 2 | 3 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 3 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 3 |
By publication year. Applications have been published since 2001.
Recent patents
- Cardiotonic steroid antagonists and related methods22 Sep 2020US 10,781,431 B2Marshall University Research Corporation
- Biomarkers useful in liver fibrosis diagnosis29 May 2018US 9,983,216 B2Industrial Technology Research Institute
- Antibodies that bind urokinase plasminogen activator6 Mar 2018US 9,908,944 B2Novo Nordisk A/S
- Biomarkers useful in liver fibrosis diagnosis17 Oct 2017US 9,791,460 B2Industrial Technology Research Institute
- Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples8 Jun 2010US 7,732,159 B2Siemens Healthcare Diagnostics Inc.
- Novel Treatment of Diabetes and Kidney Disease by Inhibition of D2D3 a Proteolytic UPAR25 Sep 2025US 2025/0296999 A1Massachusetts General Hospital
- Protein biomarkers of inflammatory activity in multiple sclerosis12 Jun 2025US 2025/0189541 A1Oklahoma Medical Research Foundation
- Development of novel upar single-domain antibody6 Mar 2025US 2025/0074997 A1Persongen Biotherapeutics (Suzhou) Co., Ltd.
- Sars-cov-2 infection risk assessment method27 Jul 2023US 2023/0236196 A1Copenhagen University Hospital Amager and Hvidovre
- Methods of diagnosing tuberculosis and differentiating between active and latent tuberculosis7 Apr 2022US 2022/0106627 A1Cepheid
Most cited
By later US patents
- Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers44US 5,453,359 AAmerican Biogenetic Sciences, Inc. · 1995
- Modified proenzymes as substrates for proteolytic enzymes40US 5,811,252 ANederlandse Organisatie voor toegepast-natuurwetenschappelijk onderzoek TNO · 1998
- Ligand screening and design by X-ray crystallography28US 6,297,021 B1Abbott Laboratories · 2001
- Detecting and distinguishing between plasminogen activators25US 4,629,694 ACornell Research Foundation, Inc. · 1986
- Easily split substrates for the quantification of proteases21US 4,279,810 AAB Kabi · 1981